Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction

Dean J. Kereiakes, Robert M. Califf, Barry S. George, Stephen Ellis, Joseph Samaha, Richard Stack, Linda H. Martin, Sharon Young, Eric J. Topol

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Coronary bypass surgery was performed prior to hospital discharge in 303 (22%) of 1387 consecutive patients enrolled in the TAMI 1 to 3 and 5 trials of intravenous thrombolytic therapy for acute myocardial infarction. Bypass surgery was of emergency nature (<24 hours from treatment with intravenous thrombolytic therapy) in 36 (2.6%) and was deferred (>24 hours) in 267 (19.3%) patients. The indications for bypass surgery included falled angioplasty (12%); left main or equivalent coronary disease (9%); complex or multivessel coronary disease (62%); recurrent postinfarction angina (13%); and refractory pump dysfunction, mitral regurgitation, ventricular septal rupture or abnormal predischarge functional test (1% each). Although patients having bypass surgery were older (59.5 ± 9.8 versus 56.0 ± 10.2 years, (p < 0.0001), had more extensive coronary artery disease (46% with three-vessel disease versus 11%, (p < 0.0001), had more frequent diabetes mellitus (19% versus 15%, (p = 0.048), had more prior infarctions (p < 0.0001), had more severe initial depression in global left ventricular ejection fraction (48.0 ± 11.9% versus 51.8 ± 11.9%, p = 0.0002), and regional infarct zone (-2.7 ± 0.94 versus -2.5 ± 1.1 SD/chord, p = 0.02) and noninfarct zone function (-0.36 ± 1.8 versus 0.43 ± 1.6 SD/chord, p < 0.0001) than patients not having coronary bypass surgery, no difference in the incidence of death in hospital (7% surgical versus 6% nonsurgical) or death at long-term follow-up of hospital survivors (7% surgical versus 6% nonsurgical) was noted between groups. Surgical patients demonstrated a greater degree of recovery in left ventricular ejection fraction (3.4 ± 9.8% versus 0.16 ± 8.5%, p = 0.036) and infarct zone regional function (0.71 ± 1.1 versus 0.34 ± 0.99 SD/chord, p = 0.001) when immediate (90 minutes following initiation of thrombolytic therapy) and predischarge (7 to 14 days after treatment) contrast left ventriculograms were compared than did patients who received only intravenous thrombolytic therapy with or without coronary angioplasty. These data suggest a beneficial influence of coronary bypass surgery on left ventricular function and possibly on the clinical outcome of patients initially treated with intravenous thrombolytic therapy for acute myocardial infarction.

Original languageEnglish
Pages (from-to)390-399
Number of pages10
JournalAmerican Heart Journal
Volume122
Issue number2
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Thrombolytic Therapy
Left Ventricular Function
Myocardial Infarction
Angioplasty
Stroke Volume
Coronary Disease
Ventricular Septal Rupture
Mitral Valve Insufficiency
Infarction
Survivors
Coronary Artery Disease
Diabetes Mellitus
Emergencies
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction. / Kereiakes, Dean J.; Califf, Robert M.; George, Barry S.; Ellis, Stephen; Samaha, Joseph; Stack, Richard; Martin, Linda H.; Young, Sharon; Topol, Eric J.

In: American Heart Journal, Vol. 122, No. 2, 01.01.1991, p. 390-399.

Research output: Contribution to journalArticle

Kereiakes, DJ, Califf, RM, George, BS, Ellis, S, Samaha, J, Stack, R, Martin, LH, Young, S & Topol, EJ 1991, 'Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction', American Heart Journal, vol. 122, no. 2, pp. 390-399. https://doi.org/10.1016/0002-8703(91)90991-P
Kereiakes, Dean J. ; Califf, Robert M. ; George, Barry S. ; Ellis, Stephen ; Samaha, Joseph ; Stack, Richard ; Martin, Linda H. ; Young, Sharon ; Topol, Eric J. / Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction. In: American Heart Journal. 1991 ; Vol. 122, No. 2. pp. 390-399.
@article{2bc96c6703fe4192ad252e94e0101705,
title = "Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction",
abstract = "Coronary bypass surgery was performed prior to hospital discharge in 303 (22{\%}) of 1387 consecutive patients enrolled in the TAMI 1 to 3 and 5 trials of intravenous thrombolytic therapy for acute myocardial infarction. Bypass surgery was of emergency nature (<24 hours from treatment with intravenous thrombolytic therapy) in 36 (2.6{\%}) and was deferred (>24 hours) in 267 (19.3{\%}) patients. The indications for bypass surgery included falled angioplasty (12{\%}); left main or equivalent coronary disease (9{\%}); complex or multivessel coronary disease (62{\%}); recurrent postinfarction angina (13{\%}); and refractory pump dysfunction, mitral regurgitation, ventricular septal rupture or abnormal predischarge functional test (1{\%} each). Although patients having bypass surgery were older (59.5 ± 9.8 versus 56.0 ± 10.2 years, (p < 0.0001), had more extensive coronary artery disease (46{\%} with three-vessel disease versus 11{\%}, (p < 0.0001), had more frequent diabetes mellitus (19{\%} versus 15{\%}, (p = 0.048), had more prior infarctions (p < 0.0001), had more severe initial depression in global left ventricular ejection fraction (48.0 ± 11.9{\%} versus 51.8 ± 11.9{\%}, p = 0.0002), and regional infarct zone (-2.7 ± 0.94 versus -2.5 ± 1.1 SD/chord, p = 0.02) and noninfarct zone function (-0.36 ± 1.8 versus 0.43 ± 1.6 SD/chord, p < 0.0001) than patients not having coronary bypass surgery, no difference in the incidence of death in hospital (7{\%} surgical versus 6{\%} nonsurgical) or death at long-term follow-up of hospital survivors (7{\%} surgical versus 6{\%} nonsurgical) was noted between groups. Surgical patients demonstrated a greater degree of recovery in left ventricular ejection fraction (3.4 ± 9.8{\%} versus 0.16 ± 8.5{\%}, p = 0.036) and infarct zone regional function (0.71 ± 1.1 versus 0.34 ± 0.99 SD/chord, p = 0.001) when immediate (90 minutes following initiation of thrombolytic therapy) and predischarge (7 to 14 days after treatment) contrast left ventriculograms were compared than did patients who received only intravenous thrombolytic therapy with or without coronary angioplasty. These data suggest a beneficial influence of coronary bypass surgery on left ventricular function and possibly on the clinical outcome of patients initially treated with intravenous thrombolytic therapy for acute myocardial infarction.",
author = "Kereiakes, {Dean J.} and Califf, {Robert M.} and George, {Barry S.} and Stephen Ellis and Joseph Samaha and Richard Stack and Martin, {Linda H.} and Sharon Young and Topol, {Eric J.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0002-8703(91)90991-P",
language = "English",
volume = "122",
pages = "390--399",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction

AU - Kereiakes, Dean J.

AU - Califf, Robert M.

AU - George, Barry S.

AU - Ellis, Stephen

AU - Samaha, Joseph

AU - Stack, Richard

AU - Martin, Linda H.

AU - Young, Sharon

AU - Topol, Eric J.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Coronary bypass surgery was performed prior to hospital discharge in 303 (22%) of 1387 consecutive patients enrolled in the TAMI 1 to 3 and 5 trials of intravenous thrombolytic therapy for acute myocardial infarction. Bypass surgery was of emergency nature (<24 hours from treatment with intravenous thrombolytic therapy) in 36 (2.6%) and was deferred (>24 hours) in 267 (19.3%) patients. The indications for bypass surgery included falled angioplasty (12%); left main or equivalent coronary disease (9%); complex or multivessel coronary disease (62%); recurrent postinfarction angina (13%); and refractory pump dysfunction, mitral regurgitation, ventricular septal rupture or abnormal predischarge functional test (1% each). Although patients having bypass surgery were older (59.5 ± 9.8 versus 56.0 ± 10.2 years, (p < 0.0001), had more extensive coronary artery disease (46% with three-vessel disease versus 11%, (p < 0.0001), had more frequent diabetes mellitus (19% versus 15%, (p = 0.048), had more prior infarctions (p < 0.0001), had more severe initial depression in global left ventricular ejection fraction (48.0 ± 11.9% versus 51.8 ± 11.9%, p = 0.0002), and regional infarct zone (-2.7 ± 0.94 versus -2.5 ± 1.1 SD/chord, p = 0.02) and noninfarct zone function (-0.36 ± 1.8 versus 0.43 ± 1.6 SD/chord, p < 0.0001) than patients not having coronary bypass surgery, no difference in the incidence of death in hospital (7% surgical versus 6% nonsurgical) or death at long-term follow-up of hospital survivors (7% surgical versus 6% nonsurgical) was noted between groups. Surgical patients demonstrated a greater degree of recovery in left ventricular ejection fraction (3.4 ± 9.8% versus 0.16 ± 8.5%, p = 0.036) and infarct zone regional function (0.71 ± 1.1 versus 0.34 ± 0.99 SD/chord, p = 0.001) when immediate (90 minutes following initiation of thrombolytic therapy) and predischarge (7 to 14 days after treatment) contrast left ventriculograms were compared than did patients who received only intravenous thrombolytic therapy with or without coronary angioplasty. These data suggest a beneficial influence of coronary bypass surgery on left ventricular function and possibly on the clinical outcome of patients initially treated with intravenous thrombolytic therapy for acute myocardial infarction.

AB - Coronary bypass surgery was performed prior to hospital discharge in 303 (22%) of 1387 consecutive patients enrolled in the TAMI 1 to 3 and 5 trials of intravenous thrombolytic therapy for acute myocardial infarction. Bypass surgery was of emergency nature (<24 hours from treatment with intravenous thrombolytic therapy) in 36 (2.6%) and was deferred (>24 hours) in 267 (19.3%) patients. The indications for bypass surgery included falled angioplasty (12%); left main or equivalent coronary disease (9%); complex or multivessel coronary disease (62%); recurrent postinfarction angina (13%); and refractory pump dysfunction, mitral regurgitation, ventricular septal rupture or abnormal predischarge functional test (1% each). Although patients having bypass surgery were older (59.5 ± 9.8 versus 56.0 ± 10.2 years, (p < 0.0001), had more extensive coronary artery disease (46% with three-vessel disease versus 11%, (p < 0.0001), had more frequent diabetes mellitus (19% versus 15%, (p = 0.048), had more prior infarctions (p < 0.0001), had more severe initial depression in global left ventricular ejection fraction (48.0 ± 11.9% versus 51.8 ± 11.9%, p = 0.0002), and regional infarct zone (-2.7 ± 0.94 versus -2.5 ± 1.1 SD/chord, p = 0.02) and noninfarct zone function (-0.36 ± 1.8 versus 0.43 ± 1.6 SD/chord, p < 0.0001) than patients not having coronary bypass surgery, no difference in the incidence of death in hospital (7% surgical versus 6% nonsurgical) or death at long-term follow-up of hospital survivors (7% surgical versus 6% nonsurgical) was noted between groups. Surgical patients demonstrated a greater degree of recovery in left ventricular ejection fraction (3.4 ± 9.8% versus 0.16 ± 8.5%, p = 0.036) and infarct zone regional function (0.71 ± 1.1 versus 0.34 ± 0.99 SD/chord, p = 0.001) when immediate (90 minutes following initiation of thrombolytic therapy) and predischarge (7 to 14 days after treatment) contrast left ventriculograms were compared than did patients who received only intravenous thrombolytic therapy with or without coronary angioplasty. These data suggest a beneficial influence of coronary bypass surgery on left ventricular function and possibly on the clinical outcome of patients initially treated with intravenous thrombolytic therapy for acute myocardial infarction.

UR - http://www.scopus.com/inward/record.url?scp=0025817702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025817702&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(91)90991-P

DO - 10.1016/0002-8703(91)90991-P

M3 - Article

C2 - 1907087

AN - SCOPUS:0025817702

VL - 122

SP - 390

EP - 399

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 2

ER -